EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Role of Adjuvant Therapy in the Management of Chronic Urticaria

W Keumala Budianti, S Mahri, D Almira

Actas Dermo-Sifiliográficas · 2023

DOI: 10.1016/j.ad.2023.02.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Actas Dermo-Sifiliográficas, 2023. Verfasst von W Keumala Budianti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Chronic Urticaria, Urticaria. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent guideline on the management of urticaria recommends second-generation H1-antihistamine as the first-line therapy, with dose increases of up to fourfold if inadequately controlled. However, the treatment of chronic spontaneous urticaria (CSU) is often disappointing, so additional adjuvant therapies are needed to increase the effectiveness of first-line therapy, especially in patients who are refractory to the increase of antihistamine doses. Recent studies recommend various adjuvant therapy modalities for CSU, such as biological agents, immunosuppressants, leukotriene receptor antagonists, H2-antihistamine, sulfones, autologous serum therapy, phototherapy, vitamin D, antioxidants, and probiotics. This literature review was made to determine the effectiveness of various adjuvant therapies in managing CSU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaUrticariaHumansChronic DiseaseHistamine H1 AntagonistsCombined Modality TherapyOmalizumab

Stichwörter der Autor:innen

Adjuvant therapyChronic spontaneous urticariaComplementary therapyTerapia adyuvanteTerapia complementariaUrticaria crónica espontánea

Substanzen

Histamine H1 AntagonistsOmalizumab

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia.
  • Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia. Electronic address: donnalmira19@gmail.com.

Zitieren

APA

Keumala Budianti, W., Mahri, S., & Almira, D. (2023). The Role of Adjuvant Therapy in the Management of Chronic Urticaria. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2023.02.015

Vancouver

Keumala Budianti W, Mahri S, Almira D. The Role of Adjuvant Therapy in the Management of Chronic Urticaria. Actas Dermo-Sifiliográficas. 2023. doi:10.1016/j.ad.2023.02.015

BibTeX
@article{KeumalaBudianti2023,
  author = {Keumala Budianti, W and Mahri, S and Almira, D},
  title = {The Role of Adjuvant Therapy in the Management of Chronic Urticaria},
  journal = {Actas Dermo-Sifiliográficas},
  year = {2023},
  doi = {10.1016/j.ad.2023.02.015}
}
Kostenlos starten →